Binding mechanism of inositol stereoisomers to monomers and aggregates of Aβ(16-22)

Journal of Physical Chemistry B

Volumn 117, Issue 22, 2013, Pages 6603-6613

  Li, Grace ^a,b   Pomeìs, Régis ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; ALCOHOLS; AMINO ACIDS; GLYCOPROTEINS; ISOMERS; MOLECULAR DYNAMICS; MONOMERS; NEURODEGENERATIVE DISEASES; STEREOCHEMISTRY; SUGARS;

ALZHEIMER'S DISEASE; AMYLOID FORMATION; BINDING MECHANISMS; BINDING SPECIFICITIES; INHIBITORY CONCENTRATION; MOLECULAR BASIS; MOLECULAR DYNAMICS SIMULATIONS; PEPTIDE FRAGMENTS;

POLYOLS;

EID: 84879137514     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp311350r     Document Type: Article

References (84)

1. Citron, M. Alzheimer's Disease: Strategies for Disease Modification Nat. Rev. Drug Discovery 2010, 9, 387-398
2. Solomon, B.; Frenkel, D. Immunotherapy for Alzheimer's Disease Neuropharmacology 2010, 59, 303-309
3. Haass, C.; Selkoe, D. Soluble Protein Oligomers in Neurodegeneration: Lessons from the Alzheimer's Amyloid β-Peptide Nat. Rev. Mol. Cell. Biol. 2007, 8, 101-112
4. Citron, M.; Westaway, D.; Xia, W.; Carlson, G.; Diehl, T.; Levesque, G.; Johnson-wood, K.; Lee, M.; Seubert, P.; Davis, A. Mutant Presenilins of Alzheimer's Disease Increase Production of 42-Residue Amyloid β-Protein in Both Transfected Cells and Transgenic Mice Nat. Med. 1997, 3, 67-72
5. Petkova, A. T.; Ishii, Y.; Balbach, J. J.; Antzutkin, O. N.; Leapman, R. D.; Delaglio, F.; Tycko, R. A Structural Model for Alzheimer's β-Amyloid Fibrils Based on Experimental Constraints from Solid State NMR Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16742-16747
6. Balbach, J. J.; Ishii, Y.; Antzutkin, O. N.; Leapman, R. D.; Rizzo, N. W.; Dyda, F.; Reed, J.; Tycko, R. Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR Biochemistry 2000, 39, 13748-13759
7. Sawaya, M.; Sambashivan, S.; Nelson, R.; Ivanova, M.; Sievers, S.; Apostol, M.; Thompson, M.; Balbirnie, M.; Wiltzius, J.; McFarlane, H. Atomic Structures of Amyloid Cross-β Spines Reveal Varied Steric Zippers Nature 2007, 447, 453-457
8. Wood, S.; Wetzel, R.; Martin, J.; Hurle, M. Prolines and Amyloidogenicity in Fragments of the Alzheimer's Peptide β/A4 Biochemistry 1995, 34, 724-730
9. Kim, W.; Hecht, M. H. Mutations Enhance the Aggregation Propensity of the Alzheimer's Aβ Peptide J. Mol. Biol. 2008, 377, 565-574
10. Esler, W. P.; Stimson, E. R.; Ghilardi, J. R.; Lu, Y. A.; Felix, A. M.; Vinters, H. V.; Mantyh, P. W.; Lee, J. P.; Maggio, J. E. Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence Biochemistry 1996, 35, 13914-13921
11. Bernstein, S. L.; Dupuis, N. F.; Lazo, N. D.; Wyttenbach, T.; Condron, M. M.; Bitan, G.; Teplow, D. B.; Shea, J.-E.; Ruotolo, B. T.; Robinson, C. V. Amyloid-β Protein Oligomerization and the Importance of Tetramers and Dodecamers in the Aetiology of Alzheimer's Disease Nat. Chem. 2009, 1, 326-331
12. Masters, C.; Beyreuther, K. Alzheimer's Centennial Legacy: Prospects for Rational Therapeutic Intervention Targeting the Aβ Amyloid Pathway Brain 2006, 129, 2823-2839
13. Dasilva, K. A.; Shaw, J. E.; McLaurin, J. Amyloid-β Fibrillogenesis: Structural Insight and Therapeutic Intervention Exp. Neurol. 2010, 223, 311-321
14. Esteras-Chopo, A.; Morra, G.; Moroni, E.; Serrano, L.; de la Paz, M. L.; Colombo, G. A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation J. Mol. Biol. 2008, 383, 266-280
15. Sciarretta, K.; Gordon, D.; Meredith, S. Peptide-Based Inhibitors of Amyloid Assembly Methods Enzymol. 2006, 413, 273-312
16. Chalifour, R.; McLaughlin, R.; Lavoie, L.; Morissette, C.; Tremblay, N.; Boulé, M.; Sarazin, P.; Stéa, D.; Lacombe, D.; Tremblay, P. Stereoselective Interactions of Peptide Inhibitors with the β-Amyloid Peptide J. Biol. Chem. 2003, 278, 34874-34881
17. Scrocchi, L.; Chen, Y.; Waschuk, S.; Wang, F.; Cheung, S.; Darabie, A.; McLaurin, J.; Fraser, P. Design of Peptide-Based Inhibitors of Human Islet Amyloid Polypeptide Fibrillogenesis J. Mol. Biol. 2002, 318, 697-706
18. Soto, P.; Griffin, M.; Shea, J.-E. New Insights into the Mechanism of Alzheimer Amyloid-β Fibrillogenesis Inhibition by N-Methylated Peptides Biophys. J. 2007, 93, 3015-3025
19. Janus, C.; Pearson, J.; McLaurin, J.; Mathews, P. M.; Jiang, Y.; Schmidt, S. D.; Chishti, M. A.; Horne, P.; Heslin, D.; French, J. Aβ Peptide Immunization Reduces Behavioural Impairment and Plaques in a Model of Alzheimer's Disease Nature 2000, 408, 979-982
20. Masuda, M.; Hasegawa, M.; Nonaka, T.; Oikawa, T.; Yonetani, M.; Yamaguchi, Y.; Kato, K.; Hisanaga, S.; Goedert, M. Inhibition of α-synuclein Fibril Assembly by Small Molecules: Analysis Using Epitope-Specific Antibodies FEBS Lett. 2009, 583, 787-791
21. Berhanu, W.; Masunov, A. Natural Polyphenols as Inhibitors of Amyloid Aggregation. Molecular Dynamics Study of GNNQQNY Heptapeptide Decamer Biophys. Chem. 2010, 149, 12-21
22. Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG Redirects Amyloidogenic Polypeptides into Unstructured, Off-Pathway Oligomers Nat. Struct. Mol. Biol. 2008, 15, 558-566
23. Hawkes, C.; Ng, V.; McLaurin, J. Small Molecule Inhibitors of Aβ-Aggregation and Neurotoxicity Drug Dev. Res. 2009, 70, 111-124
24. Necula, M.; Kayed, R.; Milton, S.; Glabe, C. Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct J. Biol. Chem. 2007, 282, 10311-10324
25. Nitz, M.; Fenili, D.; Darabie, A. A.; Wu, L.; Cousins, J. E.; McLaurin, J. Modulation of Amyloid-β Aggregation and Toxicity By Inosose Stereoisomers FEBS J. 2008, 275, 1663-1674
26. McLaurin, J.; Kierstead, M. E.; Brown, M. E.; Hawkes, C. A.; Lambermon, M. H. L.; Phinney, A. L.; Darabie, A. A.; Cousins, J. E.; French, J. E.; Lan, M. F. Cyclohexanehexol Inhibitors of Aβ Aggregation Prevent and Reverse Alzheimer Phenotype in a Mouse Model Nat. Med. 2006, 12, 801-808
27. McLaurin, J.; Golomb, R.; Jurewicz, A.; Antel, J.; Fraser, P. Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid β Peptide and Inhibit Aβ-Induced Toxicity J. Biol. Chem. 2000, 275, 18495-18502
28. Fenili, D.; Brown, M.; Rappaport, R.; McLaurin, J. Properties of scyllo-Inositol as a Therapeutic Treatment of AD-Like Pathology J. Mol. Med. 2007, 85, 603-611
29. Ma, K.; Thomason, L. A. M.; McLaurin, J. In Current State of Alzheimer's Disease Research and Therapeutics; Advances in Pharmacology, Vol. 64; Michaelis, M.; Michaelis, E., Eds.; Elsevier Science: Amsterdam, The Netherlands, 2012; pp 177-212.
30. Fisher, S. K.; Novak, J. E.; Agranoff, B. W. Inositol and Higher Inositol Phosphates in Neural Tissues: Homeostasis, Metabolism and Functional Significance J. Neurochem. 2002, 82, 736-754
31. Salloway, S.; Sperling, R.; Keren, R.; Porsteinsson, A. P.; van Dyck, C. H.; Tariot, P. N.; Gilman, S.; Arnold, D.; Abushakra, S.; Hernandez, C. A Phase 2 Randomized Trial of ELND005, scyllo-Inositol, in Mild to Moderate Alzheimer Disease Neurology 2011, 77, 1253-1262
32. McLaurin, J.; Franklin, T.; Chakrabartty, A.; Fraser, P. Phosphatidylinositol and Inositol Involvement in Alzheimer Amyloid-β Fibril Growth and Arrest J. Mol. Biol. 1998, 278, 183-194
33. Nikolic, A.; Baud, S.; Rauscher, S.; Pomès, R. Molecular Mechanism of β-sheet Self-organization at Water-Hydrophobic Interfaces Proteins 2011, 79, 1-22
34. Rauscher, S.; Baud, S.; Miao, M.; Keeley, F. W.; Pomès, R. Proline and Glycine Control Protein Self-Organization into Elastomeric or Amyloid Fibrils Structure 2006, 14, 1667-1676
35. Li, G.; Rauscher, S.; Baud, S.; Pomès, R. Binding of Inositol Stereoisomers to Model Amyloidogenic Peptides to Model Amyloidogenic Peptides J. Phys. Chem. B 2012, 116, 1111-1119
36. Rauscher, S.; Pomès, R. Molecular Simulations of Protein Disorder Biochem. Cell. Biol. 2010, 88, 269-290
37. Sgourakis, N. G.; Merced-Serrano, M.; Boutsidis, C.; Drineas, P.; Du, Z.; Wang, C.; Garciá, A. E. Atomic-Level Characterization of the Ensemble of the Aβ(1-42) Monomer in Water Using Unbiased Molecular Dynamics Simulations and Spectral Algorithms J. Mol. Biol. 2011, 405, 570-583
38. Wang, X.; Vitalis, A.; Wyczalkowski, M. A.; Pappu, R. V. Characterizing the Conformational Ensemble of Monomeric Polyglutamine Proteins 2005, 63, 297-311
39. Cino, E. A.; Wong-ekkabut, J.; Karttunen, M.; Choy, W.-Y. Microsecond Molecular Dynamics Simulations of Intrinsically Disordered Proteins Involved in the Oxidative Stress Response PLoS One 2011, 6, e27371
40. Lemkul, J.; Bevan, D. Destabilizing Alzheimer's Aβ42 Protofibrils with Morin: Mechanistic Insights from Molecular Dynamics Simulations Biochemistry 2010, 49, 3935-3946
41. Wang, S.-H.; Liu, F.-F.; Dong, X.-Y.; Sun, Y. Thermodynamic Analysis of the Molecular Interactions Between Amyloid β-Peptide 42 and (-)-Epigallocatechin-3-gallate J. Phys. Chem. B 2010, 114, 11576-11583
42. Raman, E. P.; Takeda, T.; Klimov, D. K. Molecular Dynamics Simulations of Ibuprofen Binding to Aβ peptides Biophys. J. 2009, 97, 2070-2079
43. Takeda, T.; Chang, W. E.; Raman, E. P.; Klimov, D. K. Binding of Nonsteroidal Antiinflammatory Drugs to Aβ Fibril Proteins 2010, 78, 2849-2860
44. Wu, C.; Wang, Z.; Lei, H.; Duan, Y.; Bowers, M. T.; Shea, J.-E. The Binding of Thioflavin T and Its Neutral Analog BTA-1 to Protofibrils of the Alzheimer's Disease Aβ16-22 Peptide Probed by Molecular Dynamics Simulations J. Mol. Biol. 2008, 384, 718-729
45. Wu, C.; Bowers, M.; Shea, J.-E. On the Origin of the Stronger Binding of PIB over Thioflavin T to Protofibrils of the Alzheimer Amyloid-β Peptide: A Molecular Dynamics Study Biophys. J. 2011, 100, 1316-1324
46. Liu, F.-F.; Ji, L.; Dong, X.-Y.; Sun, Y. Molecular Insight Into the Inhibition Effect of Trehalose on the Nucleation and Elongation of Amyloid β-Peptide Oligomers J. Phys. Chem. B 2009, 113, 11320-11329
47. Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG Redirects Amyloidogenic Polypeptides into Unstructured, Off-Pathway Oligomers Nat. Struct. Mol. Biol. 2008, 15, 558-566
48. Buell, A. K.; Dobson, C. M.; Knowles, T. P. J.; Welland, M. E. Interactions Between Amyloidophilic Dyes and Their Relevance to Studies of Amyloid Inhibitors Biophys. J. 2010, 99, 3492-3497
49. LeVine, H. Multiple Ligand Binding Sites on Aβ(1-40) Fibrils Amyloid 2005, 12, 5-14
50. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids J. Am. Chem. Soc. 1996, 118, 11225-11236
51. Damm, W.; Frontera, A.; Tirado-Rives, J.; Jorgensen, W. L. OPLS All-Atom Force Field for Carbohydrates J. Comput. Chem. 1997, 18, 1955-1970
52. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water J. Chem. Phys. 1983, 79, 926-935
53. Hess, B.; Kutzner, C.; van der Spoel, D. Gromacs 4: Algorithms for Highly Efficient, Load- Balanced, and Scalable Molecular Simulation J. Chem. Theory Comput. 2008, 4, 435-447
54. Spoel, D. V. D.; Lindahl, E.; Hess, B.; Groenhof, G.; Mark, A. E.; Berendsen, H. J. C. Gromacs: Fast, Flexible, and Free J. Comput. Chem. 2005, 26, 1701-1718
55. Darden, T.; York, D.; Pedersen, L. Particle Mesh Ewald: An N·Log(N) Method for Ewald Sums in Large Systems J. Chem. Phys. 1993, 98, 10089-10092
56. Berendsen, H. J. C.; Postma, J. P. M.; Gunsteren, W. F. V.; DiNola, A.; Haak, J. Molecular Dynamics with Coupling to an External Bath J. Chem. Phys. 1984, 81, 3684-3690
57. Ryckaert, J. P.; Ciccotti, G.; Berendsen, H. J. C. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of N-Alkanes J. Comput. Phys. 1977, 23, 327-341
58. Rauscher, S.; Neale, C.; Pomès, R. Simulated Tempering Distributed Replica Sampling, Virtual Replica Exchange, and Other Generalized-Ensemble Methods for Conformational Sampling J. Chem. Theory Comput. 2009, 5, 2640-2662
59. Rodinger, T.; Howell, P.; Pomès, R. Distributed Replica Sampling J. Chem. Theory Comput. 2006, 2, 725-731
60. Kabsch, W.; Sander, C. Dictionary of Protein Secondary Structure: Pattern Recognition of Hydrogen-Bonded and Geometrical Features Biopolymers 1983, 22, 2577-2637
61. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual Molecular Dynamics J. Mol. Graph. 1996, 14, 33-38, 27-28
62. Straub, J. E.; Thirumalai, D. Toward a Molecular Theory of Early and Late Events in Monomer to Amyloid Fibril Formation Annu. Rev. Phys. Chem. 2011, 62, 437-463
63. Hilbich, C.; Kisters-Woike, B.; Reed, J.; Masters, C. L.; Beyreuther, K. Substitutions of Hydrophobic Amino Acids Reduce the Amyloidogenicity of Alzheimer's Disease βA4 Peptides J. Mol. Biol. 1992, 228, 460-473
64. Gordon, D. J.; Sciarretta, K. L.; Meredith, S. C. Inhibition of β-Amyloid(40) Fibrillogenesis and Disassembly of β-Amyloid(40) Fibrils by Short β-Amyloid Congeners Containing N-Methyl Amino Acids at Alternate Residues Biochemistry 2001, 40, 8237-8245
65. Watanabe, K.-i.; Nakamura, K.; Akikusa, S.; Okada, T.; Kodaka, M.; Konakahara, T.; Okuno, H. Inhibitors of Fibril Formation and Cytotoxicity of β-Amyloid Peptide Composed of KLVFF Recognition Element and Flexible Hydrophilic Disrupting Element Biochem. Biophys. Res. Commun. 2002, 290, 121-124
66. Inouye, H.; Fraser, P. E.; Kirschner, D. A. Structure of β-Crystallite Assemblies Formed by Alzheimer Beta-Amyloid Protein Analogues: Analysis by X-Ray Diffraction Biophys. J. 1993, 64, 502-519
67. Paravastu, A. K.; Qahwash, I.; Leapman, R. D.; Meredith, S. C.; Tycko, R. Seeded Growth of β-amyloid Fibrils from Alzheimer's Brain-derived Fibrils Produces a Distinct Fibril Structure Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 7443-7448
68. Cukalevski, R.; Boland, B.; Frohm, B.; Thulin, E.; Walsh, D.; Linse, S. Role of Aromatic Side Chains in Amyloid β-Protein Aggregation ACS Chem. Neurosci. 2012, 3, 1008-1016
69. de Groot, N. S.; Aviles, F. X.; Vendrell, J.; Ventura, S. Mutagenesis of the Central Hydrophobic Cluster in Aβ42 Alzheimer's Peptide. Side-Chain Properties Correlate with Aggregation Propensities FEBS J. 2006, 273, 658-668
70. Lührs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Döbeli, H.; Schubert, D.; Riek, R. 3D Structure of Alzheimer's Amyloid-β(1-42) Fibrils Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17342-17347
71. Wu, C.; Bowers, M. T.; Shea, J.-E. Molecular Structures of Quiescently Grown and Brain- Derived Polymorphic Fibrils of the Alzheimer Amyloid Aβ(9-40) Peptide: A Comparison to Agitated Fibrils PLoS Comput. Biol. 2010, 6, e1000693
72. Wu, C.; Scott, J.; Shea, J.-E. Binding of Congo Red to Amyloid Protofibrils of the Alzheimer Aβ9-40 Peptide Probed by Molecular Dynamics Simulations Biophys. J. 2012, 103, 550-557
73. Wu, C.; Wang, Z.; Lei, H.; Zhang, W.; Duan, Y. Dual Binding Modes of Congo Red to Amyloid Protofibril Surface Observed in Molecular Dynamics Simulations J. Am. Chem. Soc. 2007, 129, 1225-1232
74. Sun, Y.; Zhang, G.; Hawkes, C.; Shaw, J.; McLaurin, J.; Nitz, M. Synthesis of scyllo-Inositol Derivatives and Their Effects on Amyloid β Peptide Aggregation Bioorg. Med. Chem. 2008, 16, 7177-7184
75. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism Chem. Biol. Drug Des. 2006, 67, 27-37
76. Taroni, C.; Jones, S.; Thornton, J. M. Analysis and Prediction of Carbohydrate Binding Sites Protein Eng. 2000, 13, 89-98
77. Wohlert, J.; Schnupf, U.; Brady, J. W. Free Energy Surfaces for the Interaction of D-Glucose with Planar Aromatic Groups in Aqueous Solution J. Chem. Phys. 2010, 133, 155103-155111
78. Geisler, M.; Netz, R.; Hugel, T. Pulling a Single Polymer Molecule Off a Substrate Reveals the Binding Thermodynamics of Cosolutes Angew. Chem., Int. Ed. 2010, 49, 4730-4733
79. Sharon, N.; Lis, H. The Structural Basis for Carbohydrate Recognition by Lectins Adv. Exp. Med. Biol. 2001, 491, 1-16
80. Kiehna, S. E.; Laughrey, Z. R.; Waters, M. L. Evaluation of a Carbohydrate-π Interaction in a Peptide Model System Chem. Commun. 2007, 4026-4028
81. Kulharia, M.; Bridgett, S.; Goody, R.; Jackson, R. InCa-SiteFinder: A Method for Structurebased Prediction of Inositol and Carbohydrate Binding Sites on Proteins J. Mol. Graph. 2009, 28, 297-303
82. Weis, W. I.; Drickamer, K. Structural Basis of Lectin-Carbohydrate Recognition Annu. Rev. Biochem. 1996, 65, 441-473
83. Lee, Y. C.; Lee, R. T. Carbohydrate-Protein Interactions: Basis of Glycobiology Acc. Chem. Res. 1995, 28, 321-327
84. Krishnamurthy, V. M.; Estroff, L. A.; Whitesides, G. M. In Fragment-Based Approaches in Drug Discovery; Methods and Principles in Medicinal Chemistry; Jahnke, W.; Erlanson, D.; Mannhold, R.; Kubinyi, H.; Folkers, G., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2006; pp 11-19.